Metabolic blood profile and response to treatment with the pyruvate kinase activator mitapivat in patients with sickle cell disease.

Saved in:
Bibliographic Details
Title: Metabolic blood profile and response to treatment with the pyruvate kinase activator mitapivat in patients with sickle cell disease.
Authors: van Dijk MJ; Center for Benign Hematology, Thrombosis and Hemostasis-Van Creveldkliniek University Medical Center Utrecht, Utrecht University Utrecht The Netherlands.; Central Diagnostic Laboratory and Research University Medical Center Utrecht, Utrecht University Utrecht The Netherlands., Ruiter TJJ; Central Diagnostic Laboratory and Research University Medical Center Utrecht, Utrecht University Utrecht The Netherlands.; Section Metabolic Diagnostics, Department of Genetics University Medical Center Utrecht, Utrecht University Utrecht The Netherlands., van der Veen S; Center for Benign Hematology, Thrombosis and Hemostasis-Van Creveldkliniek University Medical Center Utrecht, Utrecht University Utrecht The Netherlands.; Section Metabolic Diagnostics, Department of Genetics University Medical Center Utrecht, Utrecht University Utrecht The Netherlands., Rab MAE; Central Diagnostic Laboratory and Research University Medical Center Utrecht, Utrecht University Utrecht The Netherlands.; Department of Hematology, Erasmus MC University Medical Center Rotterdam Rotterdam The Netherlands., van Oirschot BA; Central Diagnostic Laboratory and Research University Medical Center Utrecht, Utrecht University Utrecht The Netherlands., Bos J; Central Diagnostic Laboratory and Research University Medical Center Utrecht, Utrecht University Utrecht The Netherlands., Derichs C; Center for Benign Hematology, Thrombosis and Hemostasis-Van Creveldkliniek University Medical Center Utrecht, Utrecht University Utrecht The Netherlands., Rijneveld AW; Department of Hematology, Erasmus MC University Medical Center Rotterdam Rotterdam The Netherlands., Cnossen MH; Department of Pediatric Hematology, Erasmus MC Sophia Children's Hospital University Medical Center Rotterdam Rotterdam The Netherlands., Nur E; Department of Hematology Amsterdam University Medical Center, University of Amsterdam Amsterdam The Netherlands.; Department of Blood Cell Research, Sanquin Research Amsterdam The Netherlands., Biemond BJ; Department of Hematology Amsterdam University Medical Center, University of Amsterdam Amsterdam The Netherlands., Bartels M; Center for Benign Hematology, Thrombosis and Hemostasis-Van Creveldkliniek University Medical Center Utrecht, Utrecht University Utrecht The Netherlands., Schutgens REG; Center for Benign Hematology, Thrombosis and Hemostasis-Van Creveldkliniek University Medical Center Utrecht, Utrecht University Utrecht The Netherlands., van Solinge WW; Central Diagnostic Laboratory and Research University Medical Center Utrecht, Utrecht University Utrecht The Netherlands., Jans JJM; Section Metabolic Diagnostics, Department of Genetics University Medical Center Utrecht, Utrecht University Utrecht The Netherlands., van Beers EJ; Center for Benign Hematology, Thrombosis and Hemostasis-Van Creveldkliniek University Medical Center Utrecht, Utrecht University Utrecht The Netherlands., van Wijk R; Central Diagnostic Laboratory and Research University Medical Center Utrecht, Utrecht University Utrecht The Netherlands.
Source: HemaSphere [Hemasphere] 2024 Jun 25; Vol. 8 (6), pp. e109. Date of Electronic Publication: 2024 Jun 25 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2572-9241
DOI:10.1002/hem3.109